Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators...

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Alzheimer's disease (AD) is linked to amyloid-beta (Aβ) peptide aggregation.
• Small molecule modulators are investigated for AD treatment by targeting Aβ.
• Identifying drug binding sites on Aβ is vital for understanding mechanisms and drug design.

Purpose of the Study:

• To present a novel method for determining binding sites of aromatic small molecules on Aβ monomers.
• To validate the technique using a known ligand (Congo Red) and apply it to identify binding sites for other modulators.

Main Methods:

• Utilized immunostaining with Aβ sequence-specific antibodies to map ligand binding sites on Aβ monomers.
• Confirmed identified binding sites using a fluorescence quenching assay with Aβ sub-fragments.

Main Results:

• The developed immunostaining method successfully determined binding sites for Congo Red, consistent with prior research.
• Binding sites on Aβ for Erythrosin B, Eosin Y, Phloxine B, and Rose Bengal were identified using this technique.
• Results were corroborated by fluorescence quenching assays, confirming the reliability of the method.

Conclusions:

• The described immunostaining technique offers a convenient and effective way to determine Aβ monomer binding sites for aggregation-modulating ligands.
• This method enhances the ability to screen for new ligands targeting specific Aβ regions, advancing AD drug discovery.